Hripsime Martirosyan

发表

Increased Risk for Multidrug-Resistant Tuberculosis in Migratory Workers, Armenia

V. Petrosyan, B. Crape, R. Grigoryan, 2015, Emerging infectious diseases.

Phase 1 study of PSCA-targeted chimeric antigen receptor (CAR) T cell therapy for metastatic castration-resistant prostate cancer (mCRPC).

T. Dorff, P. Kuhn, S. Blanchard, 2022, Journal of Clinical Oncology.

A phase I study to evaluate PSCA-targeting chimeric antigen receptor (CAR)-T cells for patients with PSCA+ metastatic castration-resistant prostate cancer (mCRPC).

T. Dorff, P. Chu, S. Pal, 2020 .

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

L. Pachter, S. Priceman, L. Budde, 2024, Nature medicine.